IR@PKUHSC  > 北京大学第三临床医学院
学科主题临床医学
In Vivo Suppression of MicroRNA-24 Prevents the Transition Toward Decompensated Hypertrophy in Aortic-Constricted Mice
Li, Rong-Chang1,2; Tao, Jin1,2; Guo, Yun-Bo1,2; Wu, Hao-Di1,2; Liu, Rui-Feng1,2; Bai, Yan1,2; Lv, Zhi-Zhen1,2; Luo, Guan-Zheng3; Li, Lin-Lin1,2; Wang, Meng3; Yang, Hua-Qian1,2; Gao, Wei1,2; Han, Qi-De1,2; Zhang, You-Yi1,2; Wang, Xiu-Jie3; Xu, Ming1,2; Wang, Shi-Qiang1,2
关键词Ca2+ signaling hypertrophic cardiomyopathy hypertrophy heart failure myocardial contraction
刊名CIRCULATION RESEARCH
2013-02-15
DOI10.1161/CIRCRESAHA.112.300806
112期:4页:601-+
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Cardiac & Cardiovascular Systems ; Hematology ; Peripheral Vascular Disease
研究领域[WOS]Cardiovascular System & Cardiology ; Hematology
关键词[WOS]HEART-FAILURE ; CARDIAC-HYPERTROPHY ; MYOCARDIAL-INFARCTION ; CELLS ; CALCIUM ; CHANNEL ; MUSCLE
英文摘要

Rationale: During the transition from compensated hypertrophy to heart failure, the signaling between L-type Ca2+ channels in the cell membrane/T-tubules and ryanodine receptors in the sarcoplasmic reticulum becomes defective, partially because of the decreased expression of a T-tubule-sarcoplasmic reticulum anchoring protein, junctophilin-2. MicroRNA (miR)-24, a junctophilin-2 suppressing miR, is upregulated in hypertrophied and failing cardiomyocytes.

Objective: To test whether miR-24 suppression can protect the structural and functional integrity of L-type Ca2+ channel-ryanodine receptor signaling in hypertrophied cardiomyocytes.

Methods and Results: In vivo silencing of miR-24 by a specific antagomir in an aorta-constricted mouse model effectively prevented the degradation of heart contraction, but not ventricular hypertrophy. Electrophysiology and confocal imaging studies showed that antagomir treatment prevented the decreases in L-type Ca2+ channel-ryanodine receptor signaling fidelity/efficiency and whole-cell Ca2+ transients. Further studies showed that antagomir treatment stabilized junctophilin-2 expression and protected the ultrastructure of T-tubule-sarcoplasmic reticulum junctions from disruption.

Conclusions: MiR-24 suppression prevented the transition from compensated hypertrophy to decompensated hypertrophy, providing a potential strategy for early treatment against heart failure. (Circ Res. 2013; 112:601-605.)

语种英语
WOS记录号WOS:000314939400008
项目编号2011CB809101 ; 81070196 ; 30730013 ; 81030001 ; 81121061 ; XDA01020105 ; R01 TW007269
资助机构973 Program of China ; National Natural Science Foundation of China ; Chinese Academy of Sciences ; Program for New Century Excellent Talents in University ; Beijing Talents Foundation ; NIH, USA
引用统计
被引频次:51[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/61541
专题北京大学第三临床医学院
北京大学医学部管理机构_主任办公室党委办公室
北京大学第三临床医学院_心血管内科
作者单位1.Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China
2.Peking Univ, Hosp 3, Key Lab Cardiovasc Mol Biol & Regulatory Peptides, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China
3.Chinese Acad Sci, Key Lab Genet Network Biol, Inst Genet & Dev Biol, Beijing, Peoples R China
推荐引用方式
GB/T 7714
Li, Rong-Chang,Tao, Jin,Guo, Yun-Bo,et al. In Vivo Suppression of MicroRNA-24 Prevents the Transition Toward Decompensated Hypertrophy in Aortic-Constricted Mice[J]. CIRCULATION RESEARCH,2013,112(4):601-+.
APA Li, Rong-Chang.,Tao, Jin.,Guo, Yun-Bo.,Wu, Hao-Di.,Liu, Rui-Feng.,...&Wang, Shi-Qiang.(2013).In Vivo Suppression of MicroRNA-24 Prevents the Transition Toward Decompensated Hypertrophy in Aortic-Constricted Mice.CIRCULATION RESEARCH,112(4),601-+.
MLA Li, Rong-Chang,et al."In Vivo Suppression of MicroRNA-24 Prevents the Transition Toward Decompensated Hypertrophy in Aortic-Constricted Mice".CIRCULATION RESEARCH 112.4(2013):601-+.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Li, Rong-Chang]的文章
[Tao, Jin]的文章
[Guo, Yun-Bo]的文章
百度学术
百度学术中相似的文章
[Li, Rong-Chang]的文章
[Tao, Jin]的文章
[Guo, Yun-Bo]的文章
必应学术
必应学术中相似的文章
[Li, Rong-Chang]的文章
[Tao, Jin]的文章
[Guo, Yun-Bo]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。